Related Experiment Video
Updated: Feb 28, 2026

Assessment of Vascular Function in Patients With Chronic Kidney Disease
Published on: June 16, 2014
Off-pump versus on-pump coronary surgery in patients with chronic kidney disease: a meta-analysis
Yushu Wang1, Sui Zhu2, Peijuan Gao3
1Department of Cardiology, West China Hospital, Sichuan University, 37 Guoxue Street, Chengdu, 610041, Sichuan, China.
Insights
Off-pump coronary artery bypass grafting (OPCAB) significantly reduces early mortality and complications in chronic kidney disease (CKD) patients compared to on-pump coronary artery bypass grafting (ONCAB). Long-term survival remains similar for both procedures.
Area of Science:
- Cardiovascular Surgery
- Nephrology
- Critical Care Medicine
Background:
- Patients with chronic kidney disease (CKD) face higher risks of adverse cardiovascular events following coronary artery bypass grafting (CABG).
- The comparative safety and efficacy of off-pump (OPCAB) versus on-pump (ONCAB) coronary artery bypass grafting in CKD patients remain debated.
Purpose of the Study:
- To compare the postoperative outcomes of OPCAB versus ONCAB in patients with CKD.
- To determine the impact of surgical technique on early and long-term adverse cardiovascular outcomes in this high-risk population.
Main Methods:
- A comprehensive meta-analysis of studies from PubMed, Embase, and Cochrane Library databases.
- Inclusion of 17 studies involving 201,889 patients comparing OPCAB and ONCAB in CKD patients.
- Pooled analysis of odds ratios (ORs) and hazard ratios (HRs) with heterogeneity, quality, and publication bias assessments.
Main Results:
- OPCAB was associated with significantly lower early mortality (OR 0.88) in CKD patients compared to ONCAB.
- OPCAB demonstrated reduced risks of atrial fibrillation (OR 0.57), cerebrovascular accident (OR 0.46), blood transfusion (OR 0.20), pneumonia, and prolonged ventilation.
- No significant difference was observed in long-term survival (HR 1.08) or myocardial infarction rates between OPCAB and ONCAB.
Conclusions:
- OPCAB offers superior postoperative morbidity and reduced early mortality for patients with CKD undergoing coronary artery bypass grafting.
- Long-term survival outcomes are comparable between OPCAB and ONCAB in this patient cohort.
Background:
Patients with chronic kidney disease (CKD) have worse adverse cardiovascular outcomes after coronary artery bypass grafting (CABG). However, the adverse cardiovascular outcomes between off-pump coronary artery bypass grafting (OPCAB) versus on-pump coronary artery bypass grafting (ONCAB) in these patients have been a subject of debate.
Methods:
We undertook a comprehensive literature search of PubMed, Embase, and the Cochrane Library database to identify all relevant studies comparing techniques between OPCAB and ONCAB in CKD patients. We pooled the odds ratios (ORs) and hazard ratios (HRs) from individual studies and conducted heterogeneity, quality assessment, and publication bias analyses.
Results:
This meta-analysis includes 17 studies with 201,889 patients. In CKD patients, OPCAB was associated with significantly lower early mortality as compared to ONCAB (OR 0.88; 95% CI 0.82-0.93; p < 0.0001). OPCAB was associated with decreased risk of atrial fibrillation (OR 0.57; 95% CI 0.34-0.97; p = 0.04), cerebrovascular accident (OR 0.46; 95% CI 0.22-0.95; p = 0.04), blood transfusion (OR 0.20; 95% CI 0.08-0.49; p = 0.0005), pneumonia, prolonged ventilation, and shorter hospital stays. No difference was found regarding long-term survival (HR 1.08; 95% CI 0.86-1.36; p = 0.51) or myocardial infarction (OR 0.65; 95% CI 0.30-1.38; p = 0.26).
Conclusions:
Compared with ONCAB, OPCAB is associated with superior postoperative morbidity and the early mortality in CKD patients. Long-term survival is comparable between the two surgical revascularizations.
Related Concept Videos
Chronic Kidney Disease III: Interprofessional Care
Chronic Kidney Disease I: Introduction
Kidney Transplant I: Introduction
Acute Kidney Injury II: Pathophysiology
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Chronic Kidney Disease II: Clinical Manifestations

